Editorial from Editor-in-Chief

E-ISSN： 2212-4055|10|4|226-226

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.10, Iss.4, 2011-08, pp. : 226-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial from Editor-in-Chief

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 1, 2010-03 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Letter from the Editor-in-Chief of Current Radiopharmaceuticals)

Current Radiopharmaceuticals, Vol. 2, Iss. 1, 2009-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

From the Editor-in-Chief

By Catravas J.

General Pharmacology, Vol. 34, Iss. 1, 2000-01 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Letter from the Editor-in-Chief

By MOY RONALD L.

Dermatologic Surgery, Vol. 23, Iss. 1, 1997-01 ,pp. : 11-12

Elsevier

Access to resources Recommend Favorite

Message from the Editor-in-Chief:

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 1, 2016-02 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite